Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenecteplase With Concomitant Anticoagulation for Severe Acute Respiratory Failure in Patients With COVID-19

NCT04505592 is registered in ClinicalTrials.gov with Hooman Poor as lead sponsor.

NCT NCT04505592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04505592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenecteplase With Concomitant Anticoagulation for Severe Acute Respiratory Failure in Patients With COVID-19
Lead sponsor
Hooman Poor
Phase
Phase 2
Overall status
Completed
Start date
September 25, 2020
Completion date
March 10, 2022
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid-19, respiratory failure